In HNSCC, EGF family ligand expression, including EREG, associates with better responses to the EGFR inhibitor cetuximab, reflecting the increased dependence on EGFR signaling in these cancers (53). The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.